Lord, Abbett & Co »

Vaxcyte shares owned by Lord, Abbett & Co

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Lord, Abbett & Co from 13F filings

Historical chart of Lord, Abbett & Co investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Lord, Abbett & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Lord, Abbett & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $24M 386k 62.80

More positions owned by Lord, Abbett & Co

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
JPMorgan Chase & Co. (JPM)
Apple (AAPL)
UnitedHealth (UNH)
Parker-Hannifin Corporation (PH)
Comcast Corporation (CMCSA)
Amazon (AMZN)
Abbvie (ABBV)
Charles Schwab Corporation (SCHW)
Eli Lilly & Co. (LLY)
Morgan Stanley (MS)
Alphabet Inc Class A cs (GOOGL)
Arista Networks (ANET)
Exxon Mobil Corporation (XOM)

View all positions for Lord, Abbett & Co

Top funds holding Vaxcyte

Vanguard Group
RA Capital Management
Henderson Group
Wellington Management Company
T. Rowe Price Associates
Alliancebernstein
Fred Alger Management
Jennison Associates
Westfield Capital Management Company
Braidwell
Frazier Life Sciences Management
OrbiMed Advisors
Commodore Capital
Perceptive Advisors
Franklin Resources

View all funds holding Vaxcyte